Bodenstedt Matthias
- SEC CIK
- 0001920545
In the past year, 1 open-market purchase filing worth $98.8K and 5 sale filings worth $3.20M.
Current role at each company
- MLTX MoonLake ImmunotherapeuticsChief Financial Officeras of Jun 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $98.8K
- 1 filing
- Sold
- $3.20M
- 5 filings
- Net
- −$3.10M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bodenstedt Matthias as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 (view filing) | Jun 22 | 1 day | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −39.1K | $22.04 | −$862.2K | −3.4%1.12M after | 10b5-1 |
| Jun 18, 2026 (view filing) | Jun 17-18 | 1 day | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −17.9K | $19.67 | −$351.6K | −1.5%1.15M after | 2 lots10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −13.7K | $20.02 | −$273.3K | −1.2%1.17M after | 10b5-1 |
| Apr 16, 2026 (view filing) | Apr 14 | 2 days | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −2.43K | $19.56 | −$47.5K | −0.2%1.19M after | 10b5-1 |
| Apr 10, 2026 (view filing) | Apr 9-10 | 1 day | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −87.8K | $18.95 | −$1.66M | −6.9%1.19M after | 2 lots10b5-1 |
| Oct 9, 2025 (view filing) | Oct 8 | 1 day | Bodenstedt MatthiasChief Financial Officer | PPurchaseClass A ordinary shares, par value $0.0001 per share | +10.9K | $9.09 | +$98.8K | +1.8%627.5K after | |
| Dec 21, 2023 (view filing) | Dec 19-20 | 2 days | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −100.0K | $59.17 | −$5.92M | −16.1%520.9K after | 2 lots10b5-1 |